Exciting Genetic Breakthroughs: Prostate Cancer

Guest blog: Dr. Robert Bristow

Recently, exciting results were announced for an international research collaboration of more than 1,000 scientists to look at the genetic basis of prostate, breast, and ovarian cancer and pinpoint the people most likely to develop each disease. The results could eventually lead to something as simple as a saliva test based on genetic markers that provide each patient with their own personal risk profile. With that in hand, patients could receive the screening most appropriate for their level of risk – those at the highest level of risk would have more intensive medical surveillance for prostate cancer.

The impact of this research on the treatment of prostate cancer is also significant. It opens the door to identify men with a lifetime risk of 50% – men who would need a different, personalized level of interaction – focused screening, and early treatment.

These findings complement the work of a major research project underway: the 
Canadian Prostate Cancer Genome Network (CPC-GENE). The aforementioned study focuses on identifying those most at risk for prostate cancer to better direct screening efforts; it does not perfectly predict which patients have indolent disease and which patients have aggressive disease.

The goal of CPC-GENE is to “crack” that prostate cancer genetic code to be able to predict personalized treatments for non-indolent and localized intermediate risk prostate cancers – a slightly more specific goal and target population. In time, this could mean that doctors could offer additional treatment options to patients whose cancer possesses genetic components that predict success or failure of a specific treatment. The CPC-GENE and associated clinicians will then escalate therapy to a specific group of patients to reduce the risk of treatment failure and improve overall rates of cure.

 





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Got Plaid?

TORONTO, ON – (May 12, 2016) – This morning marked the launch of Canada’s second annual Plaid for Dad campaign in support of Prostate Cancer Canada (PCC).
More

Prostate Cancer Canada research aims to further our understanding of subcategory of men with prostate cancer

TORONTO, ON – May 10, 2016 —Prostate Cancer Canada (PCC) has awarded research funding to Dr.
More

The Corporate Climb: Teams Step up across Canada to Raise Money for Prostate Cancer Research

Toronto, ON – March 11th, 2016 – Throughout the course of the last few weeks, teams representing corporations in Vancouver, Calgary and Toronto raised more than $600,000 for prostate cancer research and supportive care by completing Prostate Cancer Canada’s (PCC) Step Up Challenge, presented by Scotiabank.
More


Click here for news archive